TY  - JOUR
AU  - Garranzo, Marco
AU  - Segura, José
AU  - Beltrán, David
AU  - Rodríguez Gómez, Juan Miguel
AU  - Orgaz Martín, Belén
AU  - Arroyo Rodríguez, Rebeca
AU  - Alba Rubio, Claudio
AU  - Fernández Álvarez, Leonides
PY  - 2023
DO  - 10.3389/fmicb.2023.1111652
SN  - 1664-302X
UR  - https://hdl.handle.net/20.500.14352/93808
T2  - Frontiers in Microbiology
AB  - Hyperuricemia and gout are receiving an increasing scientific and medical attention because of their relatively high prevalence and their association with relevant co-morbidities. Recently, it has been suggested that gout patients have an altered gut...
LA  - eng
M2  - 1111652
KW  - Probiotics
KW  - Ligilactobacillus salivarius
KW  - Gout
KW  - Hyperuricemia
KW  - Uric acid
KW  - Inosine
KW  - Guanosine
TI  - A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines
TY  - journal article
VL  - 14
ER  -